| Filed On | Filing |
|---|---|
| 20 Oct 2021 |
8-K/A: Departure/Election of Directors or Officers; Compensation
On October 15, 2021, Mr. Christopher Staten, Interim Chief Financial Officer and Vice President of Finance of Aerie Pharmaceuticals, Inc. (the “Company”), provided notice to the Company of his resignation from his roles at the Company, e... |
| 13 Apr 2017 | 8-K/A: Financial Statements and Exhibits |
Loading...
